Literature DB >> 24751832

Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma.

Jung Il Lee1, Jean S Campbell2.   

Abstract

Entities:  

Keywords:  Cancer-associated fibroblasts; Cholangiocarcinoma; Desmoplasia; HCC; Hepatic stellate cell; Hepatocellular carcinoma

Mesh：

Substances：

Year:  2014        PMID： 24751832     DOI： 10.1016/j.jhep.2014.04.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  15 in total

Review 1.  Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.

Authors:  Lynn Jeanette Savic; Julius Chapiro; Jean-François H Geschwind
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

2.  Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.

Authors:  Elisabetta Sagrini; Massimo Iavarone; Federico Stefanini; Francesco Tovoli; Sara Vavassori; Marco Maggioni; Matteo Renzulli; Veronica Salvatore; Horia Stefanescu; Massimo Colombo; Luigi Bolondi; Fabio Piscaglia
Journal:  United European Gastroenterol J       Date:  2018-11-22       Impact factor: 4.623

Review 3.  Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity.

Authors:  Tomoko Aoki; Naoshi Nishida; Masatoshi Kudo
Journal:  J Histochem Cytochem       Date:  2021-11-09       Impact factor: 2.479

4.  Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.

Authors:  Matthias Pinter; Arndt Weinmann; Marcus-Alexander Wörns; Florian Hucke; Simona Bota; Jens U Marquardt; Dan G Duda; Rakesh K Jain; Peter R Galle; Michael Trauner; Markus Peck-Radosavljevic; Wolfgang Sieghart
Journal:  United European Gastroenterol J       Date:  2017-02-26       Impact factor: 4.623

Review 5.  Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis.

Authors:  Zhaobing Ding; Russell E Ericksen; Qian Yi Lee; Weiping Han
Journal:  Amino Acids       Date:  2021-02-28       Impact factor: 3.520

6.  Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.

Authors:  Jung-Hwan Yu; Joon Mee Kim; Ja Kyung Kim; Suk Jin Choi; Kwan Sik Lee; Jin-Woo Lee; Hye Young Chang; Jung Il Lee
Journal:  Oncotarget       Date:  2017-06-13

7.  Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.

Authors:  Yaqing Chen; Dan Liu; Pengfei Liu; Yajing Chen; Huiling Yu; Quan Zhang
Journal:  Mol Med Rep       Date:  2017-01-16       Impact factor: 2.952

8.  Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.

Authors:  Xianzheng Qin; Yuning Song
Journal:  Med Sci Monit       Date:  2020-05-21

9.  Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.

Authors:  Meng Sha; Seogsong Jeong; Bi-Jun Qiu; Ying Tong; Lei Xia; Ning Xu; Jian-Jun Zhang; Qiang Xia
Journal:  Cancer Med       Date:  2018-07-31       Impact factor: 4.452

Review 10.  Interventional Treatment for Cholangiocarcinoma.

Authors:  Hang Li; Li Chen; Guang-Yu Zhu; Xijuan Yao; Rui Dong; Jin-He Guo
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.